Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Lunglife Ai (LLAI) Share Price

Price 1.10p on 27-03-2025 at 17:30:01
Change 0.00p 0%
Buy 1.20p
Sell 1.00p
Buy / Sell LLAI Shares
Last Trade: Sell 52,000.00 at 1.00p
Day's Volume: 0
Last Close: 1.10p
Open: 1.10p
ISIN: USU5500L1045
Day's Range 1.10p - 1.10p
52wk Range: 1.10p - 35.50p
Market Capitalisation: £337k
VWAP: 0.00p
Shares in Issue: 31m

Lunglife Ai (LLAI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 52,000 1.00p Ordinary
08:37:26 - 24-Mar-25
Sell* 45,550 1.09p Ordinary
15:43:52 - 21-Mar-25
Unknown* 124,218 0.95p Ordinary
08:55:59 - 21-Mar-25
Sell* 124,218 0.95p Ordinary
08:55:59 - 21-Mar-25
Unknown* -124,218 0.95p Ordinary
Correction
08:55:59 - 21-Mar-25
Sell* 100,000 1.00p Ordinary
08:37:50 - 21-Mar-25
Sell* 249,208 1.20p Ordinary
08:20:06 - 21-Mar-25
Sell* 25,000 1.10p Ordinary
16:38:30 - 19-Mar-25
Unknown* 150,000 1.125p Ordinary
10:37:03 - 19-Mar-25
Sell* 150,000 1.1125p Ordinary
10:37:03 - 19-Mar-25
See more Lunglife Ai trades

Lunglife Ai (LLAI) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Mar 2025 (Thu) 1.10 1.10 1.10 1.10 0
26th Mar 2025 (Wed) 1.10 1.10 1.10 1.10 0
25th Mar 2025 (Tue) 1.10 1.10 1.10 1.10 0
24th Mar 2025 (Mon) 1.10 1.10 1.10 1.10 52,000
21st Mar 2025 (Fri) 1.25 1.25 1.10 1.10 518,976
20th Mar 2025 (Thu) 1.25 1.25 1.25 1.25 0
19th Mar 2025 (Wed) 1.25 1.25 1.25 1.25 175,000
18th Mar 2025 (Tue) 1.25 1.25 1.25 1.25 0
17th Mar 2025 (Mon) 1.25 1.25 1.25 1.25 16,019
14th Mar 2025 (Fri) 1.35 1.20 1.20 1.20 95,000
13th Mar 2025 (Thu) 1.40 1.40 1.35 1.35 65,000
12th Mar 2025 (Wed) 1.40 1.40 1.40 1.40 250,000
11th Mar 2025 (Tue) 1.40 1.40 1.40 1.40 0
10th Mar 2025 (Mon) 1.40 1.40 1.40 1.40 100,000
7th Mar 2025 (Fri) 1.40 1.40 1.40 1.40 625,000
6th Mar 2025 (Thu) 1.40 1.40 1.40 1.40 0
5th Mar 2025 (Wed) 1.40 1.40 1.40 1.40 0
4th Mar 2025 (Tue) 1.40 1.40 1.40 1.40 125,001
3rd Mar 2025 (Mon) 1.50 1.50 1.40 1.40 4,648
28th Feb 2025 (Fri) 1.40 1.40 1.40 1.40 38,185
See more Lunglife Ai price history

Lunglife Ai (LLAI) Regulatory News

Date Source Headline
10th Feb 2025 7:00 am RNS Change of Nominated Adviser and Joint Broker
3rd Feb 2025 7:00 am RNS Operational Update & Proposed Cancellation
19th Nov 2024 7:00 am RNS Operational update
15th Nov 2024 7:00 am RNS Block listing Interim Review
25th Oct 2024 7:00 am RNS Directorate Change
22nd Oct 2024 7:00 am RNS Cancellation & Reissue Share Options, PDMR Notice
4th Oct 2024 7:00 am RNS Options Cancellation and Re-issuance
2nd Oct 2024 7:00 am RNS LungLB® publication in peer-reviewed journal
2nd Sep 2024 7:00 am RNS-R Data Supporting LungLB to be Presented at the AMP
22nd Aug 2024 7:00 am RNS Half-year Report
See more Lunglife Ai regulatory news

Lunglife Ai (LLAI) Share News

LungLife AI shares collapse as it plots AIM exit and potential wind-up

3rd Feb 2025 12:31

(Alliance News) - LungLife AI Inc shares collapsed on Monday as it said it would seek shareholder approval to leave the AIM market and anticipates winding-up the company as it is unlikely to receive a strategic partnership offer or funding in the near term. Read More

AIM WINNERS & LOSERS: EnSilica wins deal; LungLife plots AIM exit

3rd Feb 2025 11:01

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

AIM WINNERS & LOSERS: Woodbois subscription raises over GBP1 million

19th Nov 2024 10:39

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

IN BRIEF: LungLife AI optimistic for LungLB as interim loss narrows

22nd Aug 2024 14:29

LungLife AI Inc - California-based developer of clinical diagnostic solutions for lung cancer - Pretax loss narrows 34% to USD1.9 million in the first half of 2024, from USD2.8 million. Administrative costs decrease 36% to USD1.7 million from USD2.7 million. Revenue remains negligible. Looking ahead, Chief Executive Officer Paul Pagano says: "We are delighted with the increasing recognition for LungLB as evidenced by the positive clinician feedback together with the first orders being received under our early access programme. Whilst we progress towards commercialisation, we are also actively seeking opportunities for a suitable strategic partner who aligns with our vision and has the capability to accelerate the adoption of LungLB". Read More

LungLife AI hails progress in making LungLB test more accessible

16th Aug 2024 11:57

(Alliance News) - LungLife AI Inc on Friday shared positive news for its LungLB test, which is designed to deliver information to clinicians via a blood sample for the early detection of lung cancer. Read More

See more Lunglife Ai news
FTSE 100 Latest
Value8,666.12
Change-23.47

Login to your account

Forgot Password?

Not Registered